Keyphrases
AIDS/HIV
100%
Treatment Response
100%
Black Population
100%
Hepatitis C Virus
100%
Hepatitis C Treatment
100%
Ledipasvir
100%
Virus Hepatitis
50%
Co-infected Patients
30%
Viral Load
20%
Black Men
20%
Sustained Virological Response
20%
Genotype 1
20%
Treatment Completion
10%
Antiretroviral Therapy
10%
Newark
10%
Treatment Efficacy
10%
Treatment Experience
10%
Patient Demographics
10%
Treatment Duration
10%
Response Rate
10%
Drug Interactions
10%
Cirrhosis
10%
Follow-up Data
10%
People of Color
10%
CD4 Count
10%
Hepatitis C Virus Infection
10%
High Efficacy
10%
One Percent
10%
Patient-completed
10%
Retrospective Chart Review
10%
Treatment History
10%
Direct-acting Antivirals
10%
NS5A
10%
Difficult-to-treat Patients
10%
Real-life Cohort
10%
Medicine and Dentistry
Treatment Response
100%
Human Immunodeficiency Virus
100%
Hepatitis C Virus
100%
Black Population
100%
Ledipasvir Plus Sofosbuvir
100%
Hepatitis Virus
50%
Immune Deficiency
20%
Population Research
10%
Side Effect
10%
Patient Population
10%
Antivirus Agent
10%
Liver Cirrhosis
10%
Drug Interaction
10%
Treatment Duration
10%
Hepatitis C
10%
Patient with Human Immunodeficiency Virus
10%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Hepatitis C Virus
100%
Ledipasvir Plus Sofosbuvir
100%
Virus Hepatitis
50%
Immune Deficiency
20%
Population Study
10%
Side Effect
10%
Antivirus Agent
10%
Drug Interaction
10%
Liver Cirrhosis
10%
Hepatitis C
10%
Immunology and Microbiology